Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Physiomics awarded further contract by Numab Therapeutics

(Sharecast News) - Data science company Physiomics said on Monday that it had been awarded a further contract by an existing client.

Physiomics said Numab Therapeutics had tapped it to work on a project that involves Pharmacokinetic-Pharmacodynamic modelling in support of one of Numab's oncology assets entering the clinic and will help inform dose and scheduling decisions.

Chief executive Peter Sargent said: "We are thrilled to have this opportunity to continue working with and supporting Numab on this asset through its preclinical stages as it heads into the clinic.

"Along with the project we announced with them in August 2023, this new project is a testament to the continued support we provide and the great relationships we've built".

As of 1415 GMT, Physiomics shares were up 8.28% at 1.57p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Naked Wines 'in better position' despite revenue slide
(Sharecast News) - Naked Wines cut interim losses despite a further slide in revenues on Tuesday, as it insisted it was now in a better position financially.
Berenberg ups target price for BAE on promising outlook
(Sharecast News) - Berenberg has lifted its target price for BAE Systems and reiterated a 'buy' rating on aerospace and defence giant, saying growth drivers for the business remain "compelling".
Thames Water sees sewage spills spike
(Sharecast News) - Crisis-hit Thames Water reported a spike in sewage spills and higher debts on Tuesday, but insisted it was moving closer to being on a more stable financial footing.
Goldman Sachs upgrades British Land to 'buy'
(Sharecast News) - Goldman Sachs upgraded its stance on British Land on Tuesday to 'buy' from 'neutral', citing a stronger growth outlook, as it took a look at European real estate stocks.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.